DIM
PASG icon

DLK Investment Management’s Passage Bio PASG Stock Holding History

DLK Investment Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,050
Closed -$24.4K – 97
2025
Q2 		$24.4K Buy
3,050
+400
+15% +$2.92K 0.01% 83
2025
Q1 		$18.7K Hold
2,650
– – 0.01% 84
2024
Q4 		$30.1K Sell
2,650
-550
-17% -$7.16K 0.01% 82
2024
Q3 		$44.8K Hold
3,200
– – 0.02% 99
2024
Q2 		$50.8K Hold
3,200
– – 0.02% 93
2024
Q1 		$86.4K Hold
3,200
– – 0.04% 84
2023
Q4 		$64.6K Buy
+3,200
New +$44.2K 0.03% 83

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DLK Investment Management's PASG Position: Q3 2025 in Review

DLK Investment Management sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 3,050 shares — an estimated $24.4K sold.

DLK Investment Management first reported a position in PASG in Q4 2023 and held it in 7 quarters. The position peaked at $86.4K in Q1 2024. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • DLK Investment Management reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • DLK Investment Management sold 3,050 Passage Bio shares in Q3 2025, an estimated $24.4K.
  • DLK Investment Management first reported a position in Passage Bio in Q4 2023 and held it in 7 quarters.
  • DLK Investment Management's Passage Bio position peaked at $86.4K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on DLK Investment Management's 13F filing for Q3 2025, filed 14 Oct 2025.